-
r37980778c78--82479256df3de2a2617541fdf94df1f7
Included studies with quantitative data on MDA coverage rates. -
Studies describing qualitative factors influencing coverage.
Studies describing qualitative factors influencing coverage. -
Descriptive indicators separated by schistosome species.
Descriptive indicators separated by schistosome species. -
Meta-analysis results showing pooled prevalence reduction estimates (non-trun...
Meta-analysis results showing pooled prevalence reduction estimates (non-truncated), shown for mass and targeted studies for each schistosome species, stratified by number of... -
Systematic review of community-based, school-based, and combined delivery mod...
BackgroundThe mainstay of current schistosomiasis control programs is mass preventive chemotherapy of school-aged children with praziquantel. This treatment is delivered through... -
Differential impact of mass and targeted praziquantel delivery on schistosomi...
BackgroundSchistosomiasis is a widespread public health concern in the poorest regions of the world. The principal control strategy is regular praziquantel administration to... -
Risk of bias assessment.
Table 2 Assessment of the risk of bias in individual studies based on (1) exposure determination which includes standardization of age and assessment of LUTS severity by IPSS... -
Odds ratio of prevalence reduction<sup>*</sup> for selected covariates, strat...
Odds ratio of prevalence reduction* for selected covariates, stratified by Schistosoma species (inverse variance weighted generalised linear model with robust error variance). -
r37980778c78--15334f4dd6494408092802cc917d651b
Characteristics of included studies for systematic review. -
Specific recommendations for improving MDA coverage provided in the reviewed ...
Specific recommendations for improving MDA coverage provided in the reviewed studies.
